Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 272

1.

Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort.

Cingolani A, Zona S, Girardi E, Cozzi-Lepri A, Monno L, Quiros Roldan E, Guaraldi G, Antinori A, D'Arminio Monforte A, Marcotullio S; Community-Oriented Study Group of the Icona Foundation Study Group.

HIV Med. 2015 May 11. doi: 10.1111/hiv.12226. [Epub ahead of print]

PMID:
25959419
2.

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

Lanini S, Zumla A, Ioannidis JP, Caro AD, Krishna S, Gostin L, Girardi E, Pletschette M, Strada G, Baritussio A, Portella G, Apolone G, Cavuto S, Satolli R, Kremsner P, Vairo F, Ippolito G.

Lancet Infect Dis. 2015 Apr 13. pii: S1473-3099(15)70106-4. doi: 10.1016/S1473-3099(15)70106-4. [Epub ahead of print]

PMID:
25881871
3.

Tuberculosis Transmission from Healthcare Workers to Patients and Co-workers: A Systematic Literature Review and Meta-Analysis.

Schepisi MS, Sotgiu G, Contini S, Puro V, Ippolito G, Girardi E.

PLoS One. 2015 Apr 2;10(4):e0121639. doi: 10.1371/journal.pone.0121639. eCollection 2015.

4.

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody.

Mailly L, Xiao F, Lupberger J, Wilson GK, Aubert P, Duong FH, Calabrese D, Leboeuf C, Fofana I, Thumann C, Bandiera S, Lütgehetmann M, Volz T, Davis C, Harris HJ, Mee CJ, Girardi E, Chane-Woon-Ming B, Ericsson M, Fletcher N, Bartenschlager R, Pessaux P, Vercauteren K, Meuleman P, Villa P, Kaderali L, Pfeffer S, Heim MH, Neunlist M, Zeisel MB, Dandri M, McKeating JA, Robinet E, Baumert TF.

Nat Biotechnol. 2015 May;33(5):549-54. doi: 10.1038/nbt.3179. Epub 2015 Mar 23.

PMID:
25798937
5.

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion.

Sotgiu G, Matteelli A, Getahun H, Girardi E, Sañé Schepisi M, Centis R, Migliori GB.

Eur Respir J. 2015 Apr;45(4):1170-3. doi: 10.1183/09031936.00216814. Epub 2015 Feb 19. No abstract available.

6.

Immune Status and Serial Quantiferon-TB Gold In-Tube Screening for Latent Mycobacterium tuberculosis Infection Among HIV-Infected Persons in a Country With a Low Tuberculosis Incidence.

Sañé Schepisi M, Parracino MP, Mammone A, Bellagamba R, Pinnetti C, Cicalini S, Sampaolesi A, Ammassari A, Goletti D, Girardi E.

J Infect Dis. 2015 Jun 1;211(11):1852-3. doi: 10.1093/infdis/jiv038. Epub 2015 Jan 26. No abstract available.

PMID:
25628342
7.

IL-4 specific-response in whole blood associates with human Cystic Echinococcosis and cyst activity.

Petrone L, Vanini V, Petruccioli E, Ettorre GM, Busi Rizzi E, Schininà V, Girardi E, Ludovisi A, Gómez-Morales MÁ, Pozio E, Teggi A, Goletti D.

J Infect. 2015 Mar;70(3):299-306. doi: 10.1016/j.jinf.2014.10.009. Epub 2014 Oct 22.

PMID:
25444973
8.

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication.

Pinnetti C, Lorenzini P, Cozzi-Lepri A, Sandrine O, Tommasi C, Zaccarelli M, Perno CF, Capobianchi MR, Girardi E, Antinori A, Ammassari A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19809. doi: 10.7448/IAS.17.4.19809. eCollection 2014.

9.

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.

Saracino A, Lorenzini P, Lo Caputo S, Girardi E, Castelli F, Bonfanti P, Galli M, Caramello P, Abrescia N, Mussini C, Monno L, Monforte Ad.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19769. doi: 10.7448/IAS.17.4.19769. eCollection 2014.

10.

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics.

Ammassari A, Abbate I, Orchi N, Pinnetti C, Rozera G, Libertone R, Pierro P, Martini F, Puro V, Girardi E, Antinori A, Capobianchi MR.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19676. doi: 10.7448/IAS.17.4.19676. eCollection 2014.

11.

Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohort.

Cingolani A, Zona S, Girardi E, Lepri AC, Monno L, Quiros Roldan E, Guaraldi G, Antinori A, Monforte Ad, Marcotullio S; ICONA Foundation Study.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19653. doi: 10.7448/IAS.17.4.19653. eCollection 2014.

12.

CD4 cell count and the risk of infective and non-infective serious non-AIDS events in HIV-positive persons seen for care in Italy.

Madeddu G, Monforte AD, Girardi E, Di Biagio A, Lo Caputo S, Piolini R, Marchetti G, Pellizzer G, Giacometti A, Galli L, Antinori A, Lepri AC; ICONA Foundation Study.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19509. doi: 10.7448/IAS.17.4.19509. eCollection 2014.

13.

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America.

Efsen AM, Schultze A, Post F, Panteleev A, Furrer H, Miller R, Skrahin A, Losso MH, Toibaro J, Girardi E, Miro J, Bruyand M, Obel N, Caylá J, Podlekareva D, Lundgren J, Mocroft A, Kirk O.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19505. doi: 10.7448/IAS.17.4.19505. eCollection 2014.

14.

Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013.

d'Arminio Monforte A, Galli L, Lo Caputo S, Lichtner M, Pinnetti C, Bobbio N, Francisci D, Costantini A, Cingolani A, Castelli F, Girardi E, Castagna A; ICONA Foundation Study Group.

J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):258-67. doi: 10.1097/QAI.0000000000000297.

PMID:
25314248
15.

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; TBNET.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76. doi: 10.1164/rccm.201405-0967OC.

PMID:
25303140
16.

Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.

Maricic I, Girardi E, Zajonc DM, Kumar V.

J Immunol. 2014 Nov 1;193(9):4580-9. doi: 10.4049/jimmunol.1400699. Epub 2014 Sep 26.

PMID:
25261475
17.

Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach.

Lanini S, Mammone A, Puro V, Girardi E, Bruzzi P, Ippolito G.

New Microbiol. 2014 Jul;37(3):263-76. Epub 2014 Jul 1.

18.

Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Pinnetti C, Sampaolesi A, Antinori A, Girardi E, Goletti D.

J Infect. 2014 Dec;69(6):533-45. doi: 10.1016/j.jinf.2014.06.009. Epub 2014 Jun 26.

PMID:
24975174
19.

A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis.

Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G, Goletti D.

PLoS One. 2014 May 5;9(5):e96367. doi: 10.1371/journal.pone.0096367. eCollection 2014.

20.

Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort.

Cingolani A, Cozzi-Lepri A, Ammassari A, Mussini C, Ursitti MA, Caramello P, Angarano G, Bonfanti P, De Luca A, Mura MS, Girardi E, Antinori A, Monforte AD; Icona Foundation Study group.

PLoS One. 2014 Feb 27;9(2):e89861. doi: 10.1371/journal.pone.0089861. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk